<DOC>
	<DOC>NCT01867281</DOC>
	<brief_summary>The purpose of this study is to determine the effect of aspirin desensitization on symptoms and immunologic profile of patients with aspirin-exacerbated respiratory diseases (AERD).</brief_summary>
	<brief_title>The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases</brief_title>
	<detailed_description />
	<mesh_term>Respiration Disorders</mesh_term>
	<mesh_term>Respiratory Tract Diseases</mesh_term>
	<mesh_term>Asthma, Aspirin-Induced</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Patients with clinical diagnose of aspirinexacerbated respiratory disease History of physician diagnosed asthma. History of physiacian diagnosed chronic rhinosinositis with nasal polyps. Positive reaction to aspirin challenge test. Stable asthma (postbronchodilator FEV1 of 70% or better, no increase in baseline dose of oral glucocorticoids for at least 3 months, and no history of hospitalization or emergency room visits for asthma for at least the prior 6 months). Being smoker pregnancy Current breastfeeding History of bleeding diathesis History of transient ischemic attack or stroke, or diabetes. History of abnormal hepatic function Uncontrolled hypertension or use of beta blocker medication. History of gastrointestinal ulcers or gastrointestinal bleeding.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>aspirin</keyword>
	<keyword>asthma</keyword>
	<keyword>Aspirin desensitization</keyword>
	<keyword>Aspirin induced asthma</keyword>
	<keyword>Immune System Diseases</keyword>
	<keyword>Respiratory Hypersensitivity</keyword>
</DOC>